Elan, Biogen Idec submit Antegren MAA for Crohn's

ELN and BIIB submitted to the EMEA an MAA for Antegren natalizumab to treat Crohn's disease. The humanized monoclonal antibody against integrin alpha(4) is under review to treat multiple sclerosis (MS...